Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: Results of a long-term study

Current Medical Research and Opinion

Volumn 25, Issue 5, 2009, Pages 1295-1305

  Hans, Guy ^a   Sabatowski, Rainer ^b   Binder, Andreas ^c   Boesl, Irmgard ^d   Rogers, Peter ^e   Baron, Ralf ^c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d GRÜNENTHAL GMBH   (Germany)

^e ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Lidocaine medicated plaster; Neuropathic pain; Post herpetic neuralgia; Topical administration

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; ANTIPYRETIC AGENT; LIDOCAINE;

ADULT; AGED; ALLERGIC EDEMA; ANALGESIA; APPLICATION SITE ANESTHESIA; APPLICATION SITE DERMATITIS; APPLICATION SITE ERYTHEMA; APPLICATION SITE HYPERESTHESIA; APPLICATION SITE HYPERSENSITIVITY; APPLICATION SITE INFLAMMATION; APPLICATION SITE IRRITATION; APPLICATION SITE PRURITUS; APPLICATION SITE PUSTULE; APPLICATION SITE RASH; APPLICATION SITE REACTION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSGEUSIA; ERYTHEMA; EYE IRRITATION; FEMALE; HEARING IMPAIRMENT; HUMAN; HYDROGEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; NAUSEA; OPEN STUDY; PAIN ASSESSMENT; PARESTHESIA; PHASE 3 CLINICAL TRIAL; POSTHERPETIC NEURALGIA; SKIN ALLERGY; TINNITUS; TRANSDERMAL PATCH; URTICARIA;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; BANDAGES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; OSMOLAR CONCENTRATION; PAIN MEASUREMENT; PATIENT SATISFACTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 67549145359     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990902901368     Document Type: Conference Paper

References (40)

1. Johnson RW, Whitton TL. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother 2004;5:551-559 (Pubitemid 38344310)
2. Dworkin RH, Gnann JW Jr, Oaklander AL, et al. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain 2008;9(1Supp. 1):S37-44 (Pubitemid 350309525)
3. Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol 2003;43(2):111-117 (Pubitemid 36125935)
4. Weinberg JM. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol 2007;57(6 Suppl.):S130-5 (Pubitemid 350103620)
5. Zin CS, Nissen LM, Smith MT, et al. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 2008;22(5):417-442
6. Berger A, Dukes EM, Oster G et al. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5:143-149 (Pubitemid 38879392)
7. Dworkin RH, White R, O'Connor, et al. Health care costs of acute and chronic pain associated with a diagnosis of herpes zoster. Jam Geriatr Soc 2007;55:1168-1175
8. Volpi A, Gross G, Hercogova J, et al. Current management of herpes zoster: the European view. Am J Clin Dermatol 2005;6(5):317-325 (Pubitemid 41577406)
9. Gauthier A, Breuer J, Carrington D, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2008;9:1-10
10. Choo PW, Galil K, Donahue JG, et al. Risk factors for postherpetic neuralgia. Arch Intern Med 1997;157(11):1217-1224 (Pubitemid 27251649)
11. Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 1998;5:209-227 (Pubitemid 28519152)
12. Hempenstall K, Nurmikko TJ, Johnson RW, et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005;2(7):e164 (Pubitemid 46179274)
13. Schmader KE, Dworkin RH. Natural history and treatment of herpes zoster. J Pain 2008;9(1 Suppl. 1):S3-9
14. Pappagallo M, Haldey EJ. Pharmacological management of postherpetic neuralgia. CNS Drugs 2003;17(11):771-780 (Pubitemid 37082982)
15. Galer BS. Myofascial pain and fibromyalgia syndrome. Neurology 1997;48(6):1739; author reply: 41-42
16. Wu CL, Raja SN. An update on the treatment of postherpetic neuralgia. J Pain 2008;9(1 Suppl. 1):S19-30 (Pubitemid 350309523)
17. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-251 (Pubitemid 350051570)
18. Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13(11):1153-1169 (Pubitemid 44581463)
19. Finnerup NB, Otto M, Jensen TS, et al. An evidence-based algorithm for the treatment of neuropathic pain. Med Gen Med 2007;9(2):36 (Pubitemid 46805366)
20. Hanna M, O'Brien C, Wilson MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008;12(6):804-813
21. Galer BS, Gammaitoni AR. More than 7 years of consistent neuropathic pain relief in geriatric patients. Arch Intern Med 2003;163:628 (Pubitemid 36314352)
22. Galer BS, Jensen MP, Ma T, et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002;18:297-301 (Pubitemid 35001155)
23. Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80(3):533-538 (Pubitemid 29182702)
24. Rowbotham MC, Davies PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65(1):39-44 (Pubitemid 26227686)
25. Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database of Systematic Reviews 2007;Issue 2. Art No.:CD004846. DOI: 10.1002/14651858.CD004846.pub2
26. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003;106(1-2):151-158 (Pubitemid 37329625)
27. Rehm S, Binder A, Boesl I, et al. A New Topical Lidocaine-Medicated Plaster For Post-Herpetic Neuralgia: Results Of A Multi-National, Double-Blind, Placebo-Controlled Efficacy And Safety Trial. 12th World Congress on Pain; 2008 August 17-22, 2008; Glasgow, UK, 2008
28. Electronic Medicines Compendium. Versatis® 5% medicated plaster summary of product characteristics. emc, 2008. Available at: http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=19291 [Last accessed 17 November 2008]
29. Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004;64(9):937-947 (Pubitemid 38608473)
30. Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002;36(2):236-240 (Pubitemid 34126813)
31. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30(2):191-197 (Pubitemid 18029372)
32. Stacey BR, Dworkin RH, Murphy K, et al. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial. Pain Med 2008;9(8):1202-1208
33. Galer BS, Gammaitoni AR. More than 7 years of consistent neuropathic pain relief in geriatric patients. Arch Intern Med 2003;163(5):628 (Pubitemid 36314352)
34. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 2006;7(1):43-48 (Pubitemid 43097262)
35. McQuay H. Opioids in pain management. Lancet 1999;353:2229-2232 (Pubitemid 29295264)
36. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280(21):1837- 1842 (Pubitemid 28544424)
37. Watson CP, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998;51(4):1166-1171 (Pubitemid 28473420)
38. Malonne H, Coffiner M, Fontaine D, et al. Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain. J Clin Pharm Ther 2005;30(2):113-120 (Pubitemid 41583605)
39. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998;50(6):1837-1841 (Pubitemid 28283261)
40. Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007;12(1):13-21 (Pubitemid 46744774)